School of Medicine

School of Medicine researchers are testing the effectiveness of an investigational drug for the treatment of this neuropathic pain.

The grant will establish a University center that will develop better ways to prevent and treat heart disease in diabetics.

Photo by Tim Parker(From left) Sam, Dylan and Ashley Mopkins showcase the scarves they made for their mom at the Arts as Healing program.It offers patients’ children the opportunity to take an active, artistic role in the healing process while providing a group support network.

Such analysis may one day be a primary diagnostic tool for physicians deciding on a treatment course for trauma and other critically ill patients. More medical news

Gesturing as if turning sections of a large object over his head, Michael A. Province, Ph.D., tries to communicate the scope of his research field. “It’s like we’re all manipulating different parts of a huge, multidimensional Rubik’s cube,” he says. By “we,” Province means the worldwide community of geneticists, biostatisticians, physicians and molecular biologists who […]

A bacterium that lives in the human gut adaptively shifts more than a quarter of its genes into high gear when its host’s diet changes from sugar to complex carbohydrates. This not only allows the bacteria to survive rapidly changing nutrient conditions but also helps maintain the stability of the gut’s highly complex microbial society, according to WUSM researchers.

Researchers at the School of Medicine are testing the effectiveness of an investigational drug for the treatment of sciatica pain. Sciatica involves pain in the lower back and hip that radiates down the thigh into the leg.

Bipolar disorder is often hard to diagnose in children, and it is easy to mistake the disorder’s manic phase for attention deficit hyperactivity disorder, warns Joan Luby, a child psychiatrist at the School of Medicine and St. Louis Children’s Hospital. Learn more about pediatric bipolar disorder in the following St. Louis Post-Dispatch article.

Genomic analysis may one day be a primary diagnostic tool for physicians deciding on a course of treatment for trauma and other critically ill patients in the intensive care unit (ICU), according to a new study by a national collaboration of more than 70 physicians and scientists.

Physicians believe a vaccine-induced immune response could be used to supplement other cancer therapies or to immunize high-risk people. More medical news